Free Trial

Bicycle Therapeutics (BCYC) Insider Trading & Ownership

Bicycle Therapeutics logo
$14.68 -0.32 (-2.13%)
(As of 12/20/2024 05:31 PM ET)

Bicycle Therapeutics (NASDAQ:BCYC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.50%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$21.23 M
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$683,852.68
Get BCYC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bicycle Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BCYC Insider Buying and Selling by Quarter

Bicycle Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/16/2024Bros. Advisors Lp BakerDirectorBuy500,000$15.34$7,670,000.00  
12/13/2024Bros. Advisors Lp BakerDirectorBuy985,397$13.76$13,559,062.72  
11/11/2024Travis Alvin ThompsonCAOSell6,256$25.11$157,088.16  
10/3/2024Kevin LeeCEOSell3,212$22.26$71,499.12  
10/3/2024Michael Charles Ferguso HannayInsiderSell247$22.26$5,498.22  
10/3/2024Michael SkynnerCTOSell972$22.26$21,636.72  
10/3/2024Travis Alvin ThompsonCAOSell153$22.26$3,405.78  
7/3/2024Kevin LeeCEOSell3,194$19.64$62,730.16  
7/3/2024Michael Charles Ferguso HannayInsiderSell246$19.64$4,831.44  
7/3/2024Michael SkynnerCTOSell967$19.64$18,991.88  
7/3/2024Travis Alvin ThompsonCAOSell148$19.64$2,906.72  
4/11/2024Michael Charles Ferguso HannayInsiderSell257$22.49$5,779.93  
4/3/2024Kevin LeeCEOSell3,158$23.81$75,191.98  
4/3/2024Michael SkynnerCTOSell955$23.81$22,738.55  
4/3/2024Nicholas KeenInsiderSell790$23.81$18,809.90  
4/3/2024Travis Alvin ThompsonCAOSell152$23.81$3,619.12  
1/3/2024Kevin LeeCEOSell8,703$17.50$152,302.50  
1/3/2024Nigel CrockettInsiderSell2,643$17.50$46,252.50  
1/3/2024Travis Alvin ThompsonCAOSell604$17.50$10,570.00  
(Data available from 1/1/2013 forward)

BCYC Insider Trading Activity - Frequently Asked Questions

The list of insiders at Bicycle Therapeutics includes Alistair Milnes, Bros. Advisors Lp Baker, Kevin Lee, Lee Kalowski, Michael Charles Ferguso Hannay, Michael Skynner, Nicholas Keen, Nigel Crockett, Pierre Legault, and Travis Alvin Thompson. Learn more on insiders at BCYC.

8.50% of Bicycle Therapeutics stock is owned by insiders. Learn more on BCYC's insider holdings.

The following insider purchased BCYC shares in the last 24 months: Bros. Advisors Lp Baker ($21,229,062.72).

Insiders have purchased a total of 1,485,397 BCYC shares in the last 24 months for a total of $21,229,062.72 bought.

The following insiders have sold BCYC shares in the last 24 months: Alistair Milnes ($8,840.00), Kevin Lee ($634,453.02), Lee Kalowski ($60,681.26), Michael Charles Ferguso Hannay ($16,109.59), Michael Skynner ($84,123.42), Nicholas Keen ($39,417.59), Nigel Crockett ($98,589.56), and Travis Alvin Thompson ($180,200.88).

Insiders have sold a total of 49,485 Bicycle Therapeutics shares in the last 24 months for a total of $1,122,415.32 sold.

Bicycle Therapeutics Key Executives

  • Dr. Kevin Lee M.B.A. (Age 56)
    Ph.D., CEO & Executive Director
    Compensation: $1.35M
  • Sir Gregory Paul Winter CBE (Age 73)
    FMedsci, FRS, HonFRCP, HonFTSE, Co-Founder & Non-Executive Director
    Compensation: $57.75k
  • Ms. Alethia Rene Young (Age 45)
    Chief Financial Officer
    Compensation: $581.69k
  • Dr. Santiago Arroyo M.D. (Age 64)
    Ph.D., Chief Development Officer
    Compensation: $916.98k
  • Dr. Christian Heinis
    Scientific Founder
  • Mr. Alistair Milnes (Age 50)
    Chief Operating Officer
    Compensation: $796.09k
  • Mr. Travis Thompson
    Senior VP, Chief Accounting Officer & Principal Accounting Officer
    3 recent trades
  • Dr. Michael Skynner B.sc. Ph.d. (Age 55)
    Ph.D., Chief Technology Officer
    Compensation: $881.01k
  • Dr. Nicholas Keen Ph.D. (Age 56)
    Chief Scientific Officer
  • Mr. Zafar Qadir
    General Counsel


This page (NASDAQ:BCYC) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners